Every GLP-1 conversation obsesses over molecules and prices and ignores the object in your hand. That object — pen, vial, or syringe — determines your error surface, part of your cost, and a surprising amount of your weekly experience. The FDA’s files on compounded semaglutide overdoses are, at bottom, device stories. Here is the guide to the hardware.
The four systems in circulation
First: single-dose autoinjector pens — Zepbound’s standard format and Wegovy’s. The dose is sealed inside; you uncap, press against skin, hold, done. No dial, no draw, no arithmetic. Second: multi-dose dial pens — Ozempic’s format — where one pen holds several weeks of drug and you dial each dose; a small counter and a click ritual, still no syringe. Third: single-dose vials — the format Lilly sells through its direct self-pay channel — containing exactly one dose that you draw into a provided syringe and inject. Fourth: multi-dose compounded vials, the compounding-pharmacy standard, where a vial holds many doses at a pharmacy-chosen concentration and you measure each one with an insulin syringe marked in units. The four systems deliver the same molecules and distribute risk completely differently.
Where the errors actually happen
The FDA’s public communications on compounded semaglutide describe patients drawing many times the intended dose, and the anatomy of those errors is always the same three-way confusion between milligrams (the dose your prescriber means), milliliters (the volume in the syringe), and units (the markings on an insulin syringe, where 100 units equal one milliliter). A prescription says 0.25 mg; the vial says 2.5 mg/mL; the correct draw is 0.1 mL, which is 10 units — and a patient who “takes 25 units because the dose is 0.25” has just injected two and a half times the intended amount. Change the vial concentration next refill — compounders vary it — and last month’s correct unit count becomes this month’s overdose. Nothing about this requires carelessness; it requires only ordinary humans doing pharmacy math at a bathroom counter.
The defense, if you use compounded vials
Three habits close most of the gap. Write the conversion once per vial, not per injection: when a new vial arrives, read its concentration, compute your dose’s volume and unit count, write it on the vial in marker, and have the pharmacy or program confirm the number in writing. Recheck on every refill — treat a concentration change like a new drug. And use the pharmacist: dispensing pharmacies are required to offer counseling, and a two-minute “show me the draw for my dose” call is the cheapest insurance in this entire market. A telehealth program that cannot connect you to a human who will do that has failed a basic test — one we score in our platform-quality criteria.
Reading a compounded vial’s label like an auditor
A legitimate compounded vial tells you: the drug and salt form, the concentration in mg/mL, the beyond-use date (compounded sterile products carry short windows — typically weeks, not the years of a manufactured pen), storage instructions, the pharmacy’s name and address, and a lot or batch identifier. Cross-check the pharmacy against your state board’s license lookup and note whether it is a 503A pharmacy (patient-specific prescriptions) or a 503B outsourcing facility (FDA-registered, batch-produced) — the legal difference our status file unpacks. A vial missing any of these is not a bargain; it is an exhibit.
Pens: the failure modes people don’t expect
Pens delete arithmetic but add mechanics. The common failure modes: injecting before the full hold time and losing part of the dose (each pen’s instructions specify the count — follow it literally), dialing errors on multi-dose pens when distracted, forgetting that a “new” pen from the fridge wants a few minutes at room temperature for comfort, and cold-chain abuse — a pen left in a hot car or frozen against the fridge’s back wall is a question for the pharmacist, not a shrug. Needle reuse and sharing are absolute nevers; sharps go in a proper container, and most pharmacies will tell you the local disposal route if asked.
Injection technique, briefly and honestly
Subcutaneous injection is genuinely easy, which is why programs undersell teaching it. The durable rules: rotate among abdomen, thigh, and back of upper arm rather than drilling one favorite site (rotation reduces skin irritation and absorption weirdness); avoid injecting into scars, bruises, or the two-inch ring around the navel; and let alcohol-swabbed skin dry before the needle. Site soreness for a day is common; spreading redness, warmth, or fever is a call to a clinician. None of this varies meaningfully between brand and compounded product — technique is the one fully portable skill in a switch.
What each system costs you beyond dollars
Autoinjectors buy simplicity and error-proofing at the highest manufacturing cost — part of why brand list prices sit where they do. Single-dose vials trade a small draw ritual for a meaningfully lower cash price through the manufacturer channel. Compounded multi-dose vials are the cheapest hardware in the market and concentrate every risk this article describes into the user’s hands. That is the honest trade: the least expensive system demands the most competence, and the programs selling it rarely say so out loud. Our ledger prices the programs; this page prices the attention each format demands.
Choosing, and switching, between systems
Needle-anxious people overwhelmingly do better with autoinjectors — the needle is hidden and the step count is two. Detail-oriented budget optimizers handle vials fine with the habits above. The dangerous profile is the casual vial user: comfortable enough to stop double-checking, on a product whose concentration can change under them. And any device change — compounded vial to brand pen, pen to Lilly vial — deserves one supervised first use, because a decade of injections in the old system is exactly the experience that makes people skip the new instructions. The full switching playbook, gaps and dose mapping included, is in the switching guide.
The checklist
Know your system’s name and its failure mode. On compounded vials: recompute and write the unit count on every new vial, and confirm it with the pharmacy. On pens: hold for the full count, store per label, never share. Everywhere: rotate sites, use a sharps container, and get one live walkthrough at every device change. The molecule does the pharmacology; the hardware discipline is yours.
The unit math, worked twice so it sticks
Example one: prescription 0.5 mg semaglutide weekly; vial labeled 2.5 mg/mL. Volume = 0.5 ÷ 2.5 = 0.2 mL. On a U-100 insulin syringe, 0.2 mL = 20 units. Example two: same 0.5 mg prescription, next refill arrives at 5 mg/mL — a concentration the pharmacy is fully entitled to use. Volume = 0.5 ÷ 5 = 0.1 mL = 10 units. Same dose, half the units. A patient on autopilot drawing “my usual 20” has just doubled their dose without touching the prescription. That is the entire failure mode of the compounded era in two lines of arithmetic — and the entire defense is reading the concentration on every single vial before the first draw from it.
Travel and real-world storage
All of these products live in the refrigerator long-term and tolerate limited room-temperature windows that vary by product — the label or instructions-for-use state the exact allowance, and “verify yours” is the only safe general advice. For flying: medication goes in carry-on, never checked (cargo holds freeze), with an insulated pouch for long itineraries; TSA permits injectables and sharps with medication, and a pharmacy label or prescription copy smooths questions. Hotel minibars run warm and hotel freezers run cold; a simple cooler pouch with the ice pack not touching the pen beats both. Frozen product is dead product — when in doubt, call the pharmacy before injecting, not after.
Five questions before your first compounded vial
What is the concentration in mg/mL, and what exact volume and unit count is my dose? Will you confirm that in writing? What is the beyond-use date, and does one vial actually cover the doses I’m paying for? Which pharmacy compounds this, in which state, and is it 503A or 503B? And who do I call — a human, with a number — if a vial looks cloudy, arrives warm, or the numbers don’t match? A program that answers all five without friction has passed a test most of its competitors fail.
The bottom line
Hardware is destiny in this market: autoinjectors make errors nearly impossible and cost the most; compounded vials cost the least and delegate pharmacy math to your bathroom counter. Whichever you hold, the rules fit on an index card — read every label, recompute every refill, one walkthrough per device change, rotate sites, and treat the pharmacist as part of the product you paid for.
References
FDA, Medications containing semaglutide (dosing-error reports) — fda.gov. Zepbound, Wegovy, Ozempic instructions for use — pi.lilly.com, novo-pi.com. USP beyond-use-date standards for compounded sterile preparations. Educational content, not medical advice.